Heather J. Church - Concepedia

Author

Heather J. Church

University of Manchester

Also Known As

H J Church, H. J. Church, H.J. Church, Heather Church, Heather J Church, Heather J. CHURCH, Heather J. Church

122

Publications

1.6K

Citations

H-Index

105

Concepts

All Affiliations

University of Manchester Royal Manchester Children's Hospital St Mary's Hospital St. Mary's Hospital St Mary's Hospital

About

Heather J. Church is an author at University of Manchester specializing in medicine, pathology, and lysosomal storage disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	616
2	Public Health	4	4	94
3	Biochemistry	3	3	75
4	Health Sciences	2	2	62
5	Natural Sciences	1	1	40

Heather J. Church

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Development of Cytotrophoblast Columns from Explanted First-Trimester Human Placental Villi: Role of Fibronectin and Integrin α5β11 John Aplin, T Haigh, Carolyn Jones, Biology of Reproduction	1999	183
Improved Metabolic Correction in Patients with Lysosomal Storage Disease Treated with Hematopoietic Stem Cell Transplant Compared with Enzyme Replacement Therapy Robert Wynn, J. E. Wraith, Jean Mercer, The Journal of Pediatrics TransplantationMarrow TransplantationEnzyme Replacement TherapyTransplantation MedicineHematology	2009	133
Diagnosing mucopolysaccharidosis IVA Timothy C. Wood, Katie Harvey, Michael Beck, Journal of Inherited Metabolic Disease	2013	98
Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry Francyne Kubaski, Robert W. Mason, Akiko Nakatomi, Journal of Inherited Metabolic Disease	2016	69
Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy Eveline J. Langereis, Naomi van Vlies, Heather J. Church, Molecular Genetics and Metabolism Translational MedicineMucopolysaccharidosis TypeAutoimmune DiseaseImmunodeficienciesAntibody Status	2014	58
Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10year combined experience of 2 centres Arunabha Ghosh, Weston P. Miller, Paul J. Orchard, Molecular Genetics and Metabolism Cell TherapyTransplantationMarrow TransplantationMucopolysaccharidosis TypeEnzyme Replacement Therapy	2016	57
Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations Amelia Morrone, Karen Tylee, Moeenaldeen AlSayed, Molecular Genetics and Metabolism	2014	56
Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy M. A. Saif, Brian Bigger, Karen E. Brookes, Haematologica	2012	52
Heparin cofactor II‐thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short‐ and long‐term treatment effects in mucopolysaccharide diseases Kia Langford‐Smith, Jean Mercer, June Petty, Journal of Inherited Metabolic Disease ImmunodeficienciesImmunologyPathologyChondroitin Sulphate RatioInflammation	2010	50
Laminins 2 and 4 are expressed by human decidual cells. Heather J. Church, Ljiljana Vićovac, Jason Williams, PubMed	1996	49

Page 1